Cardiovascular laboratory, Department of Pharmacology, School of Pharmacy, Nantong University, Nantong, 226001, China.
Cardiovascular laboratory, Department of Pharmacology, School of Pharmacy, Nantong University, Nantong, 226001, China.
Biochem Biophys Res Commun. 2020 Jul 12;528(1):71-77. doi: 10.1016/j.bbrc.2020.05.010. Epub 2020 May 26.
O-GlcNAcylation was first found by Torres and Hart in monocytes. It is a dynamic and reversible post-translational modification catalyzed by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). O-GlcNAcylation is increased in diabetic cardiomyopathy (DCM) patients and it has been reported that OGT plays an important role in the regulation of cardiac gene transcription, cell cycle and calcium homeostasis. The purpose of this study is to investigate the effects of OGT on signal transduction and function of β1-adrenoceptor (β1AR) in adult rat cardiomyocytes. We found that after overexpressing OGT by adenovirus vector in adult rat cardiomyocytes, cAMP formation and phosphorylation of phospholamban (PLB) at Ser16 (p16-PLB) were decreased under isoprenaline (ISO) stimulation. Over expression of OGT increased the intracellular [Ca]i and deteriorated the death of cardiomyocytes induced by prolonged stimulation with ISO. β1-adrenoceptor was overexpressed using a plasmid vector and then co-immunoprecipitation (co-IP) followed by Western blot was employed to define the O-GlcNAcylation of β1-adrenoceptor. The results showed that O-GlcNAcylation of β1-adrenoceptor was increased in OGT overexpressed cells, and there was no significant change in the formation of cAMP and phosphorylation of PLB after β1-adrenoceptor was blocked by CGP20712A. Given that OGT affects the signal transduction of β1-adrenoceptor in adult rat cardiomyocytes by increasing the O-GlcNAcylation of β1-adrenoceptor, the mechanism revealed in this study indicates that OGT and β1AR may be therapeutic targets in patients undergoing diabetic cardiomyopathy.
O-GlcNAc 化首先由 Torres 和 Hart 在单核细胞中发现。它是一种由 O-GlcNAc 转移酶 (OGT) 和 O-GlcNAcase (OGA) 催化的动态且可逆的翻译后修饰。在糖尿病心肌病 (DCM) 患者中,O-GlcNAc 化增加,并且已经报道 OGT 在调节心脏基因转录、细胞周期和钙稳态方面发挥重要作用。本研究的目的是研究 OGT 对成年大鼠心肌细胞中 β1-肾上腺素能受体 (β1AR) 的信号转导和功能的影响。我们发现,在用腺病毒载体过表达 OGT 后,在异丙肾上腺素 (ISO) 刺激下,成年大鼠心肌细胞中的 cAMP 形成和磷蛋白 (PLB) 丝氨酸 16 位磷酸化 (p16-PLB) 减少。OGT 的过表达增加了细胞内 [Ca]i,并恶化了 ISO 延长刺激诱导的心肌细胞死亡。使用质粒载体过表达 β1-肾上腺素能受体,然后进行共免疫沉淀 (co-IP) ,随后进行 Western blot 以确定 β1-肾上腺素能受体的 O-GlcNAc 化。结果表明,在 OGT 过表达的细胞中,β1-肾上腺素能受体的 O-GlcNAc 化增加,在用 CGP20712A 阻断 β1-肾上腺素能受体后,cAMP 的形成和 PLB 的磷酸化没有明显变化。鉴于 OGT 通过增加 β1-肾上腺素能受体的 O-GlcNAc 化来影响成年大鼠心肌细胞中 β1-肾上腺素能受体的信号转导,本研究揭示的机制表明 OGT 和 β1AR 可能是糖尿病心肌病患者的治疗靶点。